跳至主要内容
临床试验/NCT07229027
NCT07229027招募中不适用

Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.

Medialis Ltd.1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2025年11月1日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
1
主要终点
Development of a Disease-Specific Questionnaire

研究概览

简要总结

We are conducting this study to develop a disease-specific instrument, a quality of life instrument and a comprehensive list of costs associated with overweight and obesity.

详细描述

Despite evidence on the burden of BMI >25, few disease-specific instruments comprehensively capture its multidimensional impact. Existing frameworks often target obesity (BMI ≥30) or patients on pharmacological or surgical therapy. Overweight and extremely obese populations are underrepresented, and economic and psychosocial dimensions are rarely integrated into severity staging.

This study, therefore, aims to systematically evaluate symptoms, comorbidities, HRQoL, and costs across the full spectrum of individuals with BMI >25, excluding those on GLP-1 therapy. Integrating clinician and patient perspectives will support the development of more inclusive severity measures and inform early intervention strategies.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient group
  • Patient is aged ≥18 years at the time of survey completion.
  • Patient has a BMI over 25 (self-reported)
  • Patient is willing to participate in all study activities.
  • Patient is able to read, write, and converse in English.
  • Healthcare professional participant must meet the following criteria for inclusion in the study:
  • HCP is aged ≥18 years at the time of survey completion.
  • HCP is suitably qualified and involved in the healthcare management of patients with a BMI over 25
  • HCP is willing to participate in all study activities.
  • HCP is able to read, write, and converse in English.

排除标准

  • A participant who meets any of the following criteria will be excluded from the study:
  • Participants do not have the cognitive capacity to provide informed consent.
  • Participants with severe co-morbidity that might affect study participation.

结局指标

主要结局

Development of a Disease-Specific Questionnaire

时间窗: 2 months

次要结局

  • Quality of Life Instrument(2 months)

研究者

发起方
Medialis Ltd.
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Ravi Jandhyala

Dr

Medialis Ltd.

研究点 (1)

Loading locations...

相似试验